ICOSAVAX, INC. Operating Income
ICOSAVAX, INC. reported Operating Income of -$25.27 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-11-14
- ICOSAVAX, INC. operating income (loss) for the quarter ending 2023-09-30 was -$25.27M.
- ICOSAVAX, INC. operating income (loss) for the quarter ending 2023-06-30 was -$28.95M.
- ICOSAVAX, INC. operating income (loss) for the quarter ending 2023-03-31 was -$26.52M.
- ICOSAVAX, INC. operating income (loss) for the quarter ending 2022-12-31 was -$25.13M.
- ICOSAVAX, INC. operating income (loss) for fiscal 2022 was -$95.06M.
- ICOSAVAX, INC. operating income (loss) for fiscal 2021 was -$65.86M.
- ICOSAVAX, INC. operating income (loss) for fiscal 2020 was -$18.71M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$25.27M 10-Q · filed 2023-11-14 | -$54.23M derived: sum of 2 quarters · filed 2023-11-14 | -$80.75M 10-Q · filed 2023-11-14 | -$105.88M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | -$28.95M 10-Q · filed 2023-08-14 | -$55.48M 10-Q · filed 2023-08-14 | -$80.61M derived: sum of 3 quarters · filed 2023-08-14 | -$103.75M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | -$26.52M 10-Q · filed 2023-05-10 | -$51.65M derived: sum of 2 quarters · filed 2023-05-10 | -$74.80M derived: sum of 3 quarters · filed 2023-11-14 | -$97.93M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | -$25.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$48.27M derived: sum of 2 quarters · filed 2023-11-14 | -$71.41M derived: sum of 3 quarters · filed 2023-11-14 | -$95.06M 10-K · filed 2023-03-30 |
| 2022-09-30 | -$23.14M 10-Q · filed 2023-11-14 | -$46.27M derived: sum of 2 quarters · filed 2023-11-14 | -$69.93M 10-Q · filed 2023-11-14 | -$88.14M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$23.13M 10-Q · filed 2023-08-14 | -$46.78M 10-Q · filed 2023-08-14 | -$65.00M derived: sum of 3 quarters · filed 2023-08-14 | -$99.41M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$23.65M 10-Q · filed 2023-05-10 | -$41.86M derived: sum of 2 quarters · filed 2023-05-10 | -$76.28M derived: sum of 3 quarters · filed 2023-05-10 | -$84.87M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$18.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$52.62M derived: sum of 2 quarters · filed 2023-03-30 | -$61.22M derived: sum of 3 quarters · filed 2023-03-30 | -$65.86M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$34.41M 10-Q · filed 2022-11-14 | -$43.01M derived: sum of 2 quarters · filed 2022-11-14 | -$47.65M 10-Q · filed 2022-11-14 | -$52.16M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$8.59M 10-Q · filed 2022-08-15 | -$13.24M 10-Q · filed 2022-08-15 | -$17.75M derived: sum of 3 quarters · filed 2022-08-15 | -$23.21M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$4.64M 10-Q · filed 2022-05-16 | -$9.16M derived: sum of 2 quarters · filed 2022-05-16 | -$14.61M derived: sum of 3 quarters · filed 2022-05-16 | -$19.82M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$9.97M derived: sum of 2 quarters · filed 2022-03-30 | -$15.18M derived: sum of 3 quarters · filed 2022-03-30 | -$18.71M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$5.46M 10-Q · filed 2021-11-15 | -$10.66M derived: sum of 2 quarters · filed 2021-11-15 | -$14.20M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$5.21M 10-Q · filed 2021-09-13 | -$8.74M 10-Q · filed 2021-09-13 |